author

 
 

Meta

Lisa Jarvis
Japan Times
COMMENTARY / World
Jun 8, 2022
The drug that could transform breast cancer treatment
The early success of Enhertu, from AstraZeneca and Daiichi Sankyo, bodes well for an entire class of medicines that may one day replace conventional chemotherapy.
Japan Times
COMMENTARY / World
Jun 5, 2022
Omicron is turning out to be a weak vaccine
Unvaccinated people who got COVID-19 last winter have little protection from reinfection, and even vaccinated people might be vulnerable after only a few months.
Japan Times
COMMENTARY / World
May 25, 2022
Monkeypox isn’t looking like a COVID-sized threat
It's still early, but contact-tracing efforts and analysis of the virus's genome offer hope that this outbreak can be contained.
Japan Times
COMMENTARY / World
Apr 8, 2022
Confronting AI’s potential to create new chemical weapons
Although the immediate danger seems minimal, efforts are needed to safeguard machine-learning models used in chemical and drug discovery.
Japan Times
COMMENTARY / World
Mar 9, 2022
Crispr might actually live up to its immense hype
The Nobel prize-winning technology is moving from a concept to the clinic at a breathtaking pace.

Longform

Akiko Trush says her experience with the neurological disorder dystonia left her feeling like she wanted to chop her own hand off.
The neurological disorder that 'kills culture'